Early full donor myeloid chimerism after reduced-intensity stem cell transplantation using a combination of fludarabine and busulfan

H. Niiya, Y. Kanda, T. Saito, T. Ohnishi, S. Kanai, Y. Kawano, K. Kamijo, A. Iizuka, K. Yakushuin, K. Ueda, A. Chizuka, K. Idima, M. Ohnishi, K. Nakai, A. Makimoto, R. Tanosaki, K. Tobinai, H. Wakasugi, Y. Takaue, S. Mineishi

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background and Objectives. The aim of this study was to evaluate lineage-specific chimerism reconstitution after reduced-intensity allogeneic stem cell transplantation (RIST) using a combination of fludarabine (30 mg/m2 for 6 days) and busulfan (4 mg/kg for 2 days). Design and Methods. We prospectively enrolled 8 consecutive patients with hematologic malignancies who were not candidates for conventional transplantation because of either high age or organ dysfunction. Host-donor chimerism was evaluated using polymerase chain reaction-based amplification of a polymorphic short tandem repeat region. Results. All of our patients achieved engraftment within a median of 11 days after transplantation. On day 30, full donor myeloid cell chimerism (<90%) was achieved in 7 patients whereas full donor T-cell chimerism was achieved in only one patient. Thus, in contrast to other reported results, full donor chimerism was achieved earlier in the myeloid lineage than the T-cell lineage. On day 60, however, T-cell chimerism caught up with myeloid chimerism. Two patients developed grade II-IV acute graft-versus-host disease (GVHD) before the detection of full donor T-cell chimerism. Interpretation and Conclusions. Our findings suggest that the kinetics of lineage-specific chimerism depend on the agents used in the conditioning regimen, and may provide insight into the chimerism kinetics and pathogenesis of GVHD. Thus, the strategy for controlling immunosuppression after RIST should be modified according to the type of conditioning regimen applied.

Original languageEnglish
Pages (from-to)1071-1074
Number of pages4
JournalHaematologica
Volume86
Issue number10
Publication statusPublished - 2001 Nov 15
Externally publishedYes

Keywords

  • Busulfan
  • Chimerism
  • Fludarabine
  • Reduced-intensity stem cell transplantation
  • Short tandem repeat

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Early full donor myeloid chimerism after reduced-intensity stem cell transplantation using a combination of fludarabine and busulfan'. Together they form a unique fingerprint.

  • Cite this

    Niiya, H., Kanda, Y., Saito, T., Ohnishi, T., Kanai, S., Kawano, Y., Kamijo, K., Iizuka, A., Yakushuin, K., Ueda, K., Chizuka, A., Idima, K., Ohnishi, M., Nakai, K., Makimoto, A., Tanosaki, R., Tobinai, K., Wakasugi, H., Takaue, Y., & Mineishi, S. (2001). Early full donor myeloid chimerism after reduced-intensity stem cell transplantation using a combination of fludarabine and busulfan. Haematologica, 86(10), 1071-1074.